Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorman Broadb Regulatory News (NBB)

Share Price Information for Norman Broadb (NBB)

Share Price is delayed by 15 minutes
Get Live Data
194.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 8.00 (4.211%)
Market Cap: £3.60m
NBB Live PriceLast checked at - London Stock Exchange

Intraday Norman Broadb Share Chart

Subscription

6 Dec 2021 10:18

RNS Number : 6619U
Norman Broadbent PLC
06 December 2021
 

This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended ("MAR"). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

 6th December 2021

Norman Broadbent plc

("Norman Broadbent", "NBB" or the "Group")

Subscription

The board of Norman Broadbent (AIM: NBB) (the "Board"), a leading London quoted Professional Services firm offering a diversified portfolio of integrated Leadership Acquisition & Advisory Services, announces that it has raised £75,347 before expenses by way of a subscription of 1,116,252 ordinary shares ("Ordinary Shares") at 6.75 pence per Ordinary Share (the "Issue Price") ("the Subscription Shares") (the "Subscription").

The Issue Price represents a premium of approximately 12.5 per cent to the closing mid-market price of NBB's existing Ordinary Shares on 3rd December 2021 (being the last business day prior to this Announcement).

The Subscription is not being underwritten and is conditional on admission of the Subscription Shares to trading on AIM. The Subscription is being conducted pursuant to the existing authorities granted to the Directors of the Company at its annual general meeting on 25 June 2021. The Subscription Shares represent approximately 1.8 per cent. of the Company's issued share capital as enlarged by the Subscription Shares.

Application has been made to the London Stock Exchange for the Subscription Shares to be admitted to trading on AIM ("Admission") and it is expected that such Admission will occur at 8.00 a.m. 7th December 2021. The Subscription Shares will be issued credited as fully paid and will rank in full for all dividends and other distributions declared, made or paid after the admission of the Subscription Shares, and will otherwise be identical to and rank on Admission pari passu in all respects with the existing Ordinary Shares. The Subscription Shares are not being made available to the public and are not being offered or sold into any jurisdiction where it would be unlawful to do so.

Related party transactions: substantial shareholder participation

The Subscription is with one Substantial Shareholder, (as defined by the AIM Rules) who has subscribed for Subscription Shares at the Issue Price. Details of the Subscription Shares for which Substantial Shareholder will be subscribing are displayed below, together with the expected shareholdings at Admission:

Director

Number of Ordinary Shares held before the Subscription

Percentage of current issued Ordinary Share capital

Number of Subscription Shares to be subscribed for

Number of Ordinary Shares held on Admission

Percentage of enlarged Ordinary Share Capital

Downing LLP

9,800,620

16.44%

1,116,252

10,916,872

17.97%

 

 

The Substantial Shareholder participating in the Subscription will be classified as related parties under the AIM Rules. The Directors consider, having consulted with WH Ireland Limited as the Company's nominated adviser, that the terms of this transaction are fair and reasonable insofar as the Company's shareholders are concerned.

Total Voting Rights

Following Admission, the Company will have 60,740,757 Ordinary Shares in issue, none of which will be held in treasury. Accordingly, shareholders may use this figure as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.  

 

For further information, please contact:

Norman Broadbent plc

Peter Searle

Kevin Davidson

Steve Smith

 

020 7484 0000

WH Ireland Limited

Adrian Hadden

Jessica Cave

Darshan Patel

 

020 7220 1666 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDKABDKBDDOBK
Date   Source Headline
20th May 202610:40 amRNSResult of AGM
20th May 20267:00 amRNSAGM Statement
8th May 20267:00 amRNSDirectorate Change
28th Apr 20265:25 pmRNSCourt Approval of Capital Reduction
22nd Apr 20267:00 amRNSPosting of Annual Report & Notice of AGM
21st Apr 20267:00 amRNSQ1 2026 Trading Update
20th Apr 20267:00 amRNSDirectorate Change
31st Mar 20269:11 amRNSTotal Voting Rights
26th Mar 20262:00 pmRNSResult of General Meeting
25th Mar 20267:00 amRNSFinal Results
18th Mar 20268:00 amRNSHolding(s) in Company
10th Mar 20267:00 amRNSProposed Capital Reduction
9th Mar 20269:23 amRNSReplacement- Results Notice/Investor Presentation
9th Mar 20267:00 amRNSNotice of Interim Results & Investor Presentation
25th Feb 20267:00 amRNSAcquisition And Total Voting Rights
6th Feb 20267:03 amRNSDirectorate Change
21st Jan 20267:00 amRNSDirectorate Change
15th Jan 20267:00 amRNSQ4 and FY25 Trading Update
13th Oct 20257:00 amRNSQ3 2025 Trading Update
9th Sep 20257:00 amRNSChange of Auditor
8th Sep 20257:00 amRNSInterim Results
19th Aug 20257:00 amRNSNotice of Interim Results & Investor Presentation
11th Aug 20257:00 amRNSAppointment of Nominated Adviser and Sole Broker
10th Jul 20257:00 amRNSH1 2025 Trading Update
19th Jun 20252:49 pmRNSNotification of major holdings
19th Jun 20257:00 amRNSDirector/PDMR Shareholding
16th Jun 20257:00 amRNSDirector/PDMR Shareholding
22nd May 202512:58 pmRNSResult of AGM, Capital Reorganisation and TVR
22nd May 20257:00 amRNSAGM Statement
22nd Apr 20257:00 amRNSPosting of ARA & Notice of AGM
2nd Apr 20257:00 amRNSQ1 2025 Trading Update and Final Results
4th Mar 20257:00 amRNSNotice of Results & Investor Presentation
16th Jan 20257:00 amRNSTrading Update
16th Oct 20247:00 amRNSQ3 2024 Trading Update
11th Oct 20244:00 pmRNSDirector/PDMR shareholding
8th Oct 20247:00 amRNSDirector/PDMR Shareholding
3rd Oct 20247:00 amRNSChange of Registered Office
9th Sep 20247:00 amRNSInterim Results
19th Aug 20247:00 amRNSNotice of Interim Results & Investor Presentation
22nd Jul 20243:46 pmRNSNotification of major holdings
11th Jul 20247:00 amRNSH1 2024 Trading Update
23rd May 20245:29 pmRNSResult of Annual General Meeting
25th Apr 20247:00 amRNSQ1 2024 Trading Update
24th Apr 20247:00 amRNSSmall Cap Awards nomination
15th Apr 20243:18 pmRNSNotification of major holdings
8th Apr 202412:11 pmRNSIssue of Equity and Total Voting Rights
3rd Apr 20244:01 pmRNSNotification of major holdings
28th Mar 20247:00 amRNSPosting of ARA & Notice of AGM
27th Mar 20247:00 amRNSFinal Results
26th Mar 20244:07 pmRNSNotification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.